- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0030292

About Fitwel Pharmaceuticals Private Limited
Data last updated:
Fitwel Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2014PTC256071. Its GSTIN is 24AACCF4393A1Z1 (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kshitij Jain and Chandra Kant Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Jems Apt 12 1st Floor Manoj Ind Est Plot No 40A G.D. Ambekar Marg Wadala, Mumbai, Maharashtra, India – 400031.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.09 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹45.49 Lakh (net margin 1.8%) and EBITDA of ₹1.27 Cr (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 12% over five years.
The company is associated with 2 brands: Chemist Box and Fitwel Pharma. As per MCA filings, the company has open charges of ₹8.2 Cr and satisfied charges of ₹8.48 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it; 1 case is pending.
Fitwel Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0030292). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website fitwelpharma.com.
Company details
Recognitions & Rankings of Fitwel Pharmaceuticals
Contact details
Fitwel Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is fitwelpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressJems Apt 12 1st Floor Manoj Ind Est Plot No 40A G.D. Ambekar Marg Wadala, Mumbai, Maharashtra, India – 400031
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Fitwel Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Fitwel Pharmaceuticals operates two associated brands: Chemist Box and Fitwel Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Chemist Box distributes generic drugs and Ayurvedic medicine products to meet healthcare needs. | chemistbox.in | |
| Supply of Pharmaceutical, Nutraceutical, and Ayurvedic drugs with a focus on quality and distribution in India. | fitwelpharma.com |
Business activity
The main business activity of Fitwel Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fitwel Pharmaceuticals Private Limited, buy the company report.
Financials of Fitwel Pharmaceuticals Private Limited
FY 2025 filings availableFitwel Pharmaceuticals Private Limited reported revenue of ₹25.09 Cr (up 16% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 16% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.27 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹45.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Fitwel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fitwel Pharmaceuticals Private Limited
Fitwel Pharmaceuticals has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kshitij Jain Also directs: Favion Healthcare Private Limited | Director | 01 Sep 2015 | 11 Years 2 Months | Current |
| Krutika Jain | Additional Director | 15 Dec 2025 | 0 Years 10 Months | Current |
| Chandra Kant Jain | Director | 01 Sep 2015 | 11 Years 2 Months | Current |
| Bhavik Jain Also directs: Eurus Lifesciences LLP, Gelmek Healthcare Private Limited, Euraphor Lifesciences Private Limited and 1 more | Director | 15 Jul 2014 | 12 Years 3 Months | Current |
| Bhupendra Kumar Jain | Director | 15 Jul 2014 | 12 Years 3 Months | Current |
Peer comparison
Fitwel Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| JMB Pharmaceuticals Private Limited | ₹25.18 Cr (FY 2024) | 22.0% | Mumbai, Maharashtra, India | |||
| Fitwel Pharmaceuticals Private Limitedthis company | ₹25.09 Cr (FY 2025) | ₹45.49 Lakh | 1.8% | 16.0% | Mumbai, Maharashtra, India | |
| Unistar Biotech Limited | ₹25.06 Cr (FY 2025) | 57.0% | Ahmedabad, Gujarat, India | |||
| SD Jain Pharmaceuticals Private Limited | ₹25 Cr (FY 2024) | 4.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Fitwel Pharmaceuticals Private Limited, buy the company report.
Auditor
Fitwel Pharmaceuticals Private Limited is audited by ARCHIT B SHAH & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARCHIT B SHAH & ASSOCIATES | FY 2024 | 136557W |
Shareholding
The shareholding of Fitwel Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Fitwel Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Dec 2025 | 101238414 | Others | ₹7.96 Cr | Open | |
| 27 Dec 2021 | 100517276 | Hdfc Bank Limited | ₹20 Lakh | Open | |
| 06 Dec 2021 | 100532764 | Hdfc Bank Limited | ₹4.35 Lakh | Open | |
| 09 Aug 2019 | 100283104 | Hdfc Bank Limited | ₹30 Lakh | Satisfied | |
| 04 Jun 2019 | 100266645 | Hdfc Bank Limited | ₹6.58 Cr | Satisfied |
To see the full charge records of Fitwel Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Fitwel Pharmaceuticals Private Limited has 3 court cases on record: 1 filed by Fitwel Pharmaceuticals, 2 filed against it. 1 case is pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 1 |
| District courts | 1 | 0 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Ltd and 2 others | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Sun Pharmaceutical Industries Ltd and 2 others | Disposed |
| District court, Ahmedabad, Gujarat | Commercial matter | Filed by the company against Mariya Pharmaceuticals and 2 others | Disposed |
To see the full case history of Fitwel Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Fitwel Pharmaceuticals Private Limited has 2 MSME Form 1 returns on record between 2018 and 2019, listing 99 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Captab Biotec Unit II | |||
| Pharma Life Sciences | |||
| Fedex Express Transportation and Supply Chain Services (India) Private Limited | |||
| Chiros Pharma |
To see the full MSME payment records of Fitwel Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Fitwel Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCF4393A1Z1 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Fitwel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Fitwel Pharmaceuticals Private Limited has 12 board changes on record since 2014: 5 appointments and 7 cessations. The latest: Krutika Jain was appointed as Additional Director on 15 Dec 2025.
14 earlier events are in the company report.
Frequently asked questions
Fitwel Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 July 2014 (12+ years old) and is registered under CIN U24233MH2014PTC256071.
Fitwel Pharmaceuticals has 5 current directors:
- Kshitij Jain - Director
- Krutika Jain - Additional Director
- Chandra Kant Jain - Director
- Bhavik Jain - Director
- Bhupendra Kumar Jain - Director
The latest financial statements of Fitwel Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Fitwel Pharmaceuticals is 24AACCF4393A1Z1, registered in Gujarat.
The CIN (Corporate Identification Number) of Fitwel Pharmaceuticals is U24233MH2014PTC256071. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fitwel Pharmaceuticals has 3 court cases on record: 1 filed by the company and 2 filed against it. 1 is pending. Most are in the high courts.
Fitwel Pharmaceuticals was incorporated on 15 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Fitwel Pharmaceuticals by revenue are JMB Pharmaceuticals Private Limited, Unistar Biotech Limited, SD Jain Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Krutika Jain was appointed as Additional Director on 15 Dec 2025. Ullasbhai Manubhai Shah ceased to be Director on 18 Jun 2024. Jawer Bai Jain ceased to be Additional Director on 29 Sep 2023. Fitwel Pharmaceuticals has 12 board changes on record in total.
Yes, Fitwel Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0030292).
Fitwel Pharmaceuticals has 2 MSME Form 1 returns on record between 2018 and 2019, listing 99 overdue payments to 22 micro and small suppliers. The latest return was filed on 03 Jun 2019.
Fitwel Pharmaceuticals can be reached through the website fitwelpharma.com. Its registered office is in Mumbai, Maharashtra, India.

